Ask AI
ProCE Banner Activity

Elimination Starts at the Frontlines: Why Primary Care Must Be at the Forefront of Viral Hepatitis

Clinical Thought

Viral hepatitis elimination is fully within our reach, and it is up to primary care providers to initiate the care cascade by implementing universal, one-time HBV and HCV screening for all adults and offering the HBV vaccine to any adult lacking immunity. In this commentary, I discuss how primary care providers can actively halt viral transmission and connect individuals with positive test results to care.

Released: September 30, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Partners

American Liver Foundation

ProCE Banner

Target Audience

This program is intended for physicians, nurse practitioners, physician associates, pharmacists, nurses, and other HCPs who practice in primary care, infectious diseases (ID), gastroenterology (GI)/hepatology, obstetrics/gynecology (OB/GYN), addiction medicine, and other specialty and non-specialty settings who are involved in the screening, treatment, and care of individuals at risk for or living with HBV and/or HCV.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Integrate optimal screening strategies for HBV and HCV into clinical workflows across diverse care settings

  • Apply simplified approaches for HBV and HCV treatment in specialty and non-specialty settings

  • Develop evidence-based strategies to improve patient engagement with viral hepatitis care through effective shared decision-making, stigma reduction, and care navigation

Financial Disclosures

Primary Author

Su Wang, MD, MPH, FACP: researcher: Gilead Sciences.